Allogene Therapeutics所有资讯

Allogene Therapeutics | 4：持股变动声明-高管 MOORE TIMOTHY L.

04/25 04:24

Allogene Therapeutics | 4：持股变动声明-高管 Chang David D

03/19 08:16

Allogene Therapeutics | 4：持股变动声明-高管 Parker Geoffrey M.

03/07 10:55

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Arie Belldegrun, M.D.(5.8%),Bellco Legacy IV, LLC(2.8%)等

02/15 06:33

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-David Chang, M.D., Ph.D.(5.8%),Chang 2006 Family Trust(0.7%)等

02/15 05:39

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(5.37%)

02/14 06:09

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

02/09 21:40

Allogene Therapeutics | 4：持股变动声明-高管 MOORE TIMOTHY L.

02/01 06:58

Allogene Therapeutics | 4：持股变动声明-高管 Douglas Earl Martin

02/01 06:58

Allogene Therapeutics | 4：持股变动声明-高管 Parker Geoffrey M.

02/01 06:54

Allogene Therapeutics | 4：持股变动声明-董事 Belldegrun Arie

02/01 06:54

Allogene Therapeutics | 4：持股变动声明-高管 Roberts Zachary

02/01 06:49

Allogene Therapeutics | 4：持股变动声明-高管 Chang David D

02/01 06:43

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(5.9%)

01/30 06:34

Allogene Therapeutics | 4：持股变动声明-高管 Roberts Zachary

01/25 06:31

Allogene Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(1.44%)

01/23 13:00

Allogene Therapeutics | 4：持股变动声明-董事 MESSEMER DEBORAH M.

2023/12/21 05:26

Allogene Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Pfizer Inc. (“Pfizer”)(13.14%)

2023/10/26 05:29

Allogene Therapeutics | 4：持股变动声明-首席财务官 Parker Geoffrey M.

2023/10/18 05:02

Allogene Therapeutics | 3：首次持股声明-首席财务官 Parker Geoffrey M.

2023/10/17 07:25